TULSA-PRO combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The system is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while actively protecting the urethra and rectum aiming to preserve the patient’s natural functional abilities1. TULSA-PRO is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (FDA).

 1. Klotz, et al. “MP46-03-Pivotal trial of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer: Three-year follow-up”. The Journal of Urology Suppl (2021)